Breinlinger; Eric C.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Breinlinger; Eric C..The latest application filed is for "nuclear receptor modulators".
- Breinlinger; Eric C. - Charlton MA
| Patent | Date |
|---|---|
| Nuclear Receptor Modulators App 20210130293 - Argiriadi; Maria A. ; et al. | 2021-05-06 |
| Inhibitors Of Tyrosine Kinase 2 Mediated Signaling App 20200255423 - Kind Code | 2020-08-13 |
| Inhibitors of tyrosine kinase 2 mediated signaling Grant 10,508,113 - Argiriadi , et al. Dec | 2019-12-17 |
| Inhibitors Of Tyrosine Kinase 2 Mediated Signaling App 20190276450 - Argiriadi; Maria A. ; et al. | 2019-09-12 |
| Indazolones as modulators of TNF signaling Grant 10,273,238 - Breinlinger , et al. | 2019-04-30 |
| Tricyclic modulators of TNF signaling Grant 10,266,532 - Breinlinger , et al. | 2019-04-23 |
| Nuclear Receptor Modulators App 20190055196 - Argiriadi; Maria A. ; et al. | 2019-02-21 |
| Nuclear receptor modulators Grant 10,106,501 - Argiriadi , et al. October 23, 2 | 2018-10-23 |
| Indazolones As Modulators Of Tnf Signaling App 20180215764 - Breinlinger; Eric C. ; et al. | 2018-08-02 |
| Tricyclic Modulators Of Tnf Signaling App 20180179198 - Breinlinger; Eric C. ; et al. | 2018-06-28 |
| Tricyclic modulators of TNF signaling Grant 9,856,253 - Breinlinger , et al. January 2, 2 | 2018-01-02 |
| Nuclear Receptor Modulators App 20160362370 - Argiriadi; Maria A. ; et al. | 2016-12-15 |
| Tricyclic Modulators Of Tnf Signaling App 20160304517 - Breinlinger; Eric C. ; et al. | 2016-10-20 |
| Isoxazolines As Therapeutic Agents App 20150297596 - Calderwood; David J. ; et al. | 2015-10-22 |
| Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof Grant 9,115,151 - George , et al. August 25, 2 | 2015-08-25 |
| Isoxazolines as therapeutic agents Grant 9,029,409 - Calderwood , et al. May 12, 2 | 2015-05-12 |
| Novel Tricyclic Compounds App 20140349970 - Wishart; Neil ; et al. | 2014-11-27 |
| Triazinone Compounds App 20140206663 - Wang; Jianfei ; et al. | 2014-07-24 |
| Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof Grant 8,785,639 - Wishart , et al. July 22, 2 | 2014-07-22 |
| Isoxazolines as Therapeutic Agents App 20130023526 - Calderwood; David J. ; et al. | 2013-01-24 |
| Nuclear Hormone Receptor Modulators App 20120238549 - Cusack; Kevin P. ; et al. | 2012-09-20 |
| Sphingosine-1-phosphate receptor agonist and antagonist compounds Grant 8,217,027 - Wallace , et al. July 10, 2 | 2012-07-10 |
| Novel Oxadiazole Compounds App 20110207704 - Cusack; Kevin P. ; et al. | 2011-08-25 |
| Novel Tricyclic Compounds App 20110190489 - Wishart; Neil ; et al. | 2011-08-04 |
| Oxadiazole compounds Grant 7,834,039 - Hobson , et al. November 16, 2 | 2010-11-16 |
| Novel therapeutic compounds App 20090069288 - Breinlinger; Eric C. ; et al. | 2009-03-12 |
| Sphingosine-1-phosphate receptor agonist and antagonist compounds App 20090029947 - Wallace; Grier A. ; et al. | 2009-01-29 |
| Novel oxadiazole compounds App 20080280876 - Hobson; Adrian D. ; et al. | 2008-11-13 |
| Novel imidazole based heterocycles App 20080249305 - Calderwood; David J. ; et al. | 2008-10-09 |
| Novel imidazo based heterocycles App 20080242862 - Calderwood; David J. ; et al. | 2008-10-02 |
| 2-Imino-benzimidazoles App 20070232673 - Roth; Gregory P. ; et al. | 2007-10-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 